NCT05669898

Brief Summary

Multimodal analgesia (MMA) has been endorsed to improve postoperative analgesia and functional activity after surgery, and integrating regional analgesia to reduce the consumption of opioid has also been used in postoperative pain management. The investigator try to find a better combination of MMA for postoperative analgesia and functional recovery for patients receiving TKA in Taiwan, therefore the effect of single-injection and continuous infusion of peripheral nerve block is compared in patient undergoing unilateral TKA. The investigators hypothesize that continuous adductor canal infusion is as effective as single-injection adductor canal block for postoperative pain relief under intravenous PCA after TKA surgery. Based on that, the investigators conduct this prospective, randomized controlled trial to examine our hypothesis.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 21, 2019

Completed
3 years until next milestone

First Submitted

Initial submission to the registry

May 23, 2022

Completed
8 months until next milestone

First Posted

Study publicly available on registry

January 3, 2023

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2023

Completed
Last Updated

March 10, 2023

Status Verified

March 1, 2023

Enrollment Period

4 years

First QC Date

May 23, 2022

Last Update Submit

March 9, 2023

Conditions

Keywords

Arthroplasty, Replacement, KneeRegional analgesiamultimodal analgesiaRehabilitationRecovery of Function

Outcome Measures

Primary Outcomes (10)

  • Change in Pain scores at rest and motion

    Assess the pain intensity with numerical rating scale both at rest and motion in each knee. A 11 point (0-10) numerical rating scale defines 0 as no pain and 10 as the worst pain imaginable.

    Baseline (day of admission)

  • Change in Pain scores at rest and motion

    Assess the pain intensity with numerical rating scale both at rest and motion in each knee. A 11 point (0-10) numerical rating scale defines 0 as no pain and 10 as the worst pain imaginable.

    Hour 2 after surgery

  • Change in Pain scores at rest and motion

    Assess the pain intensity with numerical rating scale both at rest and motion in each knee. A 11 point (0-10) numerical rating scale defines 0 as no pain and 10 as the worst pain imaginable.

    Hour 8 after surgery

  • Change in Pain scores at rest and motion

    Assess the pain intensity with numerical rating scale both at rest and motion in each knee. A 11 point (0-10) numerical rating scale defines 0 as no pain and 10 as the worst pain imaginable.

    Hour 24 after surgery

  • Change in Pain scores at rest and motion

    Assess the pain intensity with numerical rating scale both at rest and motion in each knee. A 11 point (0-10) numerical rating scale defines 0 as no pain and 10 as the worst pain imaginable.

    Hour 36 after surgery

  • Change in Pain scores at rest and motion

    Assess the pain intensity with numerical rating scale both at rest and motion in each knee. A 11 point (0-10) numerical rating scale defines 0 as no pain and 10 as the worst pain imaginable.

    Hour 48 after surgery

  • Change in Pain scores at rest and motion

    Assess the pain intensity with numerical rating scale both at rest and motion in each knee. A 11 point (0-10) numerical rating scale defines 0 as no pain and 10 as the worst pain imaginable.

    Hour 60 after surgery

  • Change in Pain scores at rest and motion

    Assess the pain intensity with numerical rating scale both at rest and motion in each knee. A 11 point (0-10) numerical rating scale defines 0 as no pain and 10 as the worst pain imaginable.

    Hour 72 after surgery

  • Change in Pain scores at rest and motion

    Assess the pain intensity with numerical rating scale both at rest and motion in each knee. A 11 point (0-10) numerical rating scale defines 0 as no pain and 10 as the worst pain imaginable.

    1 day of discharge

  • Change in Pain scores at rest and motion

    Assess the pain intensity with numerical rating scale both at rest and motion in each knee. A 11 point (0-10) numerical rating scale defines 0 as no pain and 10 as the worst pain imaginable.

    Month 3 after surgery

Secondary Outcomes (39)

  • Rehabilitation physiotherapy: Knee flexion angle

    Baseline (day of admission)

  • Rehabilitation physiotherapy: Knee flexion angle

    Hour 24 after surgery

  • Rehabilitation physiotherapy: Knee flexion angle

    Hour 72 after surgery

  • Rehabilitation physiotherapy: Knee flexion angle

    1 Day of discharge

  • Rehabilitation physiotherapy: Knee flexion angle

    Month 3 after surgery

  • +34 more secondary outcomes

Study Arms (2)

Single-injection ACB combined with IV-PCA morphine

ACTIVE COMPARATOR

Allocation of which participant is to receive single-injection adductor canal block combined with intravenous morphine patient-controlled analgesia (IV-morphine PCA) is determined by randomization, using a computer-generated random sequence and opaque sealed envelopes. After completion of the TKA surgery and surgical suturing, adductor canal block will be performed by an anesthesiologist. Under ultrasound guidance, the femoral artery and the saphenous nerve are identified in the middle one-third of the thigh, deep to the sartorious muscle in the adductor canal. The sartorious and adductor muscles form the roof and the floor of the canal, respectively. Following skin infiltration, 20 mL of 0.25% bupivacaine with 1:400000 epinephrine is injected through a 3-inch, 23-gauge, short bevel block needle. Finally, the IV-morphine PCA will be connected to the intravenous catheter of the patient for postoperative pain management.

Behavioral: Pain scores (numerical rating scale at rest and motion): will be assessed with numerical rating scale at both rest and motion on both knees.Other: Brief Pain Inventory (Short Form), WOMAC Osteoarthritis index, and Lower extremity functional scaleBehavioral: Rehabilitation physiotherapy

Continuous adductor canal infusion combined with intravenous NSAID

ACTIVE COMPARATOR

Allocation of which participant is to receive continuous adductor canal infusion in combination with intermittent intravenous non-steroidal anti-inflammatory drug (NSAID) is determined by randomization, using a computer-generated random sequence and opaque sealed envelopes. After completion of the TKA surgery and surgical suturing, a peripheral nerve catheter will be implanted into adductor canal by an anesthesiologist. Under ultrasound guidance, the femoral artery and the saphenous nerve are identified in the middle one-third of the thigh, deep to the sartorious muscle in the adductor canal. The sartorious and adductor muscles form the roof and the floor of the canal, respectively. Following the peripheral nerve catheter is implanted, 20 mL of 0.25% bupivacaine with 1:400000 epinephrine is injected through the catheter. Intravenous tenoxicam 20 mg for a total amount of 3 doses at 24-hour interval after surgery will be added in the postoperative pain management.

Behavioral: Pain scores (numerical rating scale at rest and motion): will be assessed with numerical rating scale at both rest and motion on both knees.Other: Brief Pain Inventory (Short Form), WOMAC Osteoarthritis index, and Lower extremity functional scaleBehavioral: Rehabilitation physiotherapy

Interventions

Pain scores will be assessed with numerical rating scale at both rest and motion on both knees.

Continuous adductor canal infusion combined with intravenous NSAIDSingle-injection ACB combined with IV-PCA morphine

For the functional assessment both before and after TKA surgery.

Continuous adductor canal infusion combined with intravenous NSAIDSingle-injection ACB combined with IV-PCA morphine

Rehabilitation physiotherapy will be assessed with knee range of motion (both active and maximal passive), muscle power at abduction and adduction, single leg stance test, six-minute walk test for assessment of the functional recovery of both knees.

Continuous adductor canal infusion combined with intravenous NSAIDSingle-injection ACB combined with IV-PCA morphine

Eligibility Criteria

Age20 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical diagnosis of knee osteoarthritis
  • Must be aged between 20 to 90 years old
  • Must be scheduled for unilateral total knee arthroplasty surgery
  • Must agree to enroll into the clinical trial and have signed the written informed consent

You may not qualify if:

  • American Society of Anesthesiologists physical status class IV-V
  • Elevated liver enzymes or liver failure
  • Renal dysfunction (serum creatinine level ≥ 1.5 mg/dL)
  • Cardiac failure
  • Organ transplantation recipient
  • Stroke
  • Major neurological deficit with lower extremity muscle weakness
  • Sensory and motor disorders in lower limb
  • Coagulopathy or thrombocytopenia
  • Previous drug dependency
  • Patients who used illicit drugs within six months
  • Chronic use of opioids
  • Allergy to local anesthetics and drug used in experiment
  • Inability to walk independently
  • Inability to comprehend pain assessment
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Taipei Veterans General Hospital

Taipei, 11217, Taiwan

RECRUITING

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Hsu Ma, MD, PhD

    Institutional Review Board, Taipei Veterans General Hospital

    STUDY CHAIR

Central Study Contacts

Chun-Sung Sung, MD, PhD

CONTACT

Fang-Yao Chiu, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: A two-arm parallel assignment involves two groups of participants receiving multimodal analgesia after unilateral total knee arthroplasty. One group receives a single-injection adductor canal block combined with intravenous morphine patient-controlled analgesia, and the other group receives continuous adductor canal infusion in combination with intermittent intravenous non-steroidal anti-inflammatory drug.
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 23, 2022

First Posted

January 3, 2023

Study Start

May 21, 2019

Primary Completion

May 31, 2023

Study Completion

June 30, 2023

Last Updated

March 10, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

Locations